Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yamao

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinumN Boku, K Chin, K Hosokawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancerY Matsumura, M Gotoh, K Muro, et al.
Journal of Gastroenterology and Hepatology|March 21, 2017
Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipomaT Miyata, Y Yamashita, T Yamao, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinumN Boku, K Chin, K Hosokawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancerY Matsumura, M Gotoh, K Muro, et al.
Journal of Gastroenterology and Hepatology|March 21, 2017
Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipomaT Miyata, Y Yamashita, T Yamao, et al.
Pageof 4